• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管胃结合部癌患者管理的趋势和变化:一项基于人群的调查。

Trends and variation in the management of oesophagogastric cancer patients: a population-based survey.

机构信息

Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Institute of Public Health, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK.

出版信息

BMC Health Serv Res. 2009 Dec 15;9:231. doi: 10.1186/1472-6963-9-231.

DOI:10.1186/1472-6963-9-231
PMID:20003488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2813235/
Abstract

BACKGROUND

Previous evidence indicates potential variation in the quality of care of cancer patients. We aimed to examine whether recent changes in the treatment of oesophagogastric cancers have been distributed equally among different patient subgroups.

METHODS

We analysed population-based cancer registry data about the treatment patterning of oesophagogastric cancer (other than oesophageal squamous cell carcinoma) during 1995-2006.

RESULTS

There were 14,077 patients aged > or =40 years (69% men). There was only limited information on stage, and no information on co-morbidity status. During successive triennia, curative surgery use decreased from 28% to 20% (p < 0.001) whilst chemotherapy use increased from 9% to 30% (p < 0.001). Use of palliative surgery and of radiotherapy increased significantly but modestly (7% to 10%, and 9% to 11%, respectively). In multivariable logistic regression adjusting for age group, gender, diagnosis period and tumour type, curative surgery and chemotherapy were used less frequently in more deprived patients [per increasing deprivation group Odds Ratio (OR) = 0.96, 95% Confidence Interval (CI) 0.93-0.99, and OR = 0.90, 95%CI 0.87-0.93, respectively, p < 0.001 for both)]. Chemotherapy was also used less frequently in women (OR = 0.76, p < 0.001).

CONCLUSIONS

During the study period, curative surgery decreased by a third and chemotherapy use increased by more than three-fold, reflecting improvements in the appropriateness and quality of management, but chemotherapy use, in particular, was unequal, both by socioeconomic status and gender.

摘要

背景

以往的证据表明,癌症患者的护理质量可能存在差异。我们旨在研究在过去 15 年间,胃食管癌症(不包括食管鳞状细胞癌)的治疗模式是否在不同的患者亚组中得到了平等的分布。

方法

我们分析了 1995 年至 2006 年期间人群癌症登记处关于胃食管癌症(不包括食管鳞状细胞癌)治疗模式的数据。

结果

共有 14077 名年龄≥40 岁的患者(69%为男性)。仅有有限的关于分期的信息,没有关于合并症状态的信息。在连续的三个三年期内,根治性手术的使用率从 28%下降到 20%(p<0.001),而化疗的使用率从 9%增加到 30%(p<0.001)。姑息性手术和放疗的使用率显著增加,但幅度较小(分别从 7%增加到 10%,从 9%增加到 11%)。在多变量逻辑回归中,根据年龄组、性别、诊断期和肿瘤类型进行调整后,在更贫困的患者中,根治性手术和化疗的使用率较低[每个递增的贫困组比值比(OR)分别为 0.96(95%置信区间(CI)为 0.93-0.99)和 0.90(95%CI 为 0.87-0.93),均<0.001]。化疗在女性中的使用率也较低(OR=0.76,p<0.001)。

结论

在研究期间,根治性手术减少了三分之一,化疗的使用率增加了三倍以上,这反映了治疗的适当性和质量的提高,但特别是化疗的使用率存在不平等,既存在于社会经济地位方面,也存在于性别方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d4/2813235/1afb1a50ec32/1472-6963-9-231-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d4/2813235/8cd3ec0ebed4/1472-6963-9-231-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d4/2813235/1afb1a50ec32/1472-6963-9-231-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d4/2813235/8cd3ec0ebed4/1472-6963-9-231-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2d4/2813235/1afb1a50ec32/1472-6963-9-231-2.jpg

相似文献

1
Trends and variation in the management of oesophagogastric cancer patients: a population-based survey.食管胃结合部癌患者管理的趋势和变化:一项基于人群的调查。
BMC Health Serv Res. 2009 Dec 15;9:231. doi: 10.1186/1472-6963-9-231.
2
Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.食管癌、食管胃交界癌和胃癌多模式治疗的近期趋势及预测因素:一项荷兰队列研究。
Acta Oncol. 2015 Nov;54(10):1754-62. doi: 10.3109/0284186X.2015.1009638. Epub 2015 Mar 23.
3
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.新辅助放化疗联合手术与单纯手术治疗食管或食管胃交界癌(CROSS):一项随机对照临床试验的长期结果。
Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
4
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.年龄和合并症对食管和胃癌患者手术切除率和生存率的影响。
Br J Surg. 2012 Dec;99(12):1693-700. doi: 10.1002/bjs.8952.
5
Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.转移性食管癌和胃癌姑息性全身治疗中的剂量-疗效关系
Eur J Cancer. 2017 Jun;78:28-36. doi: 10.1016/j.ejca.2017.03.008. Epub 2017 Apr 14.
6
Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus.
Ann Oncol. 1995 Jul;6(6):551-7.
7
Sociodemographic variation in the use of chemotherapy and radiotherapy in patients with stage IV lung, oesophageal, stomach and pancreatic cancer: evidence from population-based data in England during 2013-2014.社会人口学因素对 2013-2014 年英格兰 IV 期肺癌、食管癌、胃癌和胰腺癌患者化疗和放疗应用的影响:基于人群数据的证据。
Br J Cancer. 2018 May;118(10):1382-1390. doi: 10.1038/s41416-018-0028-7. Epub 2018 May 10.
8
Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study.荷兰可切除食管癌患者根治性治疗决策及生存的决定因素:一项基于人群的研究
Cancer Epidemiol. 2015 Dec;39(6):863-9. doi: 10.1016/j.canep.2015.10.007. Epub 2015 Nov 9.
9
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.可切除食管癌新辅助化疗或放化疗后的生存:更新的荟萃分析。
Lancet Oncol. 2011 Jul;12(7):681-92. doi: 10.1016/S1470-2045(11)70142-5. Epub 2011 Jun 16.
10
Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study.≥75岁老年食管癌患者放化疗的可行性:一项前瞻性单臂II期研究。
Drugs Aging. 2009;26(3):255-62. doi: 10.2165/00002512-200926030-00006.

引用本文的文献

1
Sociodemographic variation in the use of chemotherapy and radiotherapy in patients with stage IV lung, oesophageal, stomach and pancreatic cancer: evidence from population-based data in England during 2013-2014.社会人口学因素对 2013-2014 年英格兰 IV 期肺癌、食管癌、胃癌和胰腺癌患者化疗和放疗应用的影响:基于人群数据的证据。
Br J Cancer. 2018 May;118(10):1382-1390. doi: 10.1038/s41416-018-0028-7. Epub 2018 May 10.
2
Esophageal surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it.意大利的食管手术。确定有权开展该手术的医院科室及三级转诊中心的标准。
Updates Surg. 2016 Jun;68(2):129-33. doi: 10.1007/s13304-016-0374-z. Epub 2016 May 30.
3

本文引用的文献

1
Recent incidence trends and sociodemographic features of oesophageal and gastric cancer types in an English region.英国某地区食管和胃癌类型的近期发病趋势和社会人口学特征。
Aliment Pharmacol Ther. 2009 Oct 15;30(8):873-80. doi: 10.1111/j.1365-2036.2009.04100.x. Epub 2009 Jul 18.
2
Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England.截至2007年英格兰和威尔士基于人群的癌症生存趋势:对英格兰国民健康服务癌症计划的评估。
Lancet Oncol. 2009 Apr;10(4):351-69. doi: 10.1016/S1470-2045(09)70028-2. Epub 2009 Mar 19.
3
Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis.
Determinants of treatment plan implementation in multidisciplinary team meetings for patients with chronic diseases: a mixed-methods study.
慢性病患者多学科团队会议中治疗计划实施的决定因素:一项混合方法研究。
BMJ Qual Saf. 2014 Oct;23(10):867-76. doi: 10.1136/bmjqs-2014-002818. Epub 2014 Jun 9.
4
Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases.乳腺癌诊断后的饮酒情况与生存率:基于文献的荟萃分析及对29239例病例数据的协作分析
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):934-45. doi: 10.1158/1055-9965.EPI-13-0901. Epub 2014 Mar 17.
新西兰癌症生存率方面的社会经济不平等:诊断时疾病程度的作用。
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):915-21. doi: 10.1158/1055-9965.EPI-08-0685. Epub 2009 Feb 17.
4
Cancer incidence and mortality in the United Kingdom and constituent countries, 2003-05.2003 - 2005年英国及其成员国的癌症发病率和死亡率
Health Stat Q. 2008 Winter(40):91-7.
5
No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial.在一项随机临床试验中,结直肠癌生存率不存在社会经济不平等现象。
Br J Cancer. 2008 Dec 2;99(11):1923-8. doi: 10.1038/sj.bjc.6604743. Epub 2008 Oct 28.
6
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.社会经济地位对癌症发病率及诊断时分期的影响:来自监测、流行病学及最终结果:国家纵向死亡率研究的选定发现
Cancer Causes Control. 2009 May;20(4):417-35. doi: 10.1007/s10552-008-9256-0. Epub 2008 Nov 12.
7
Survival from cancer of the stomach in England and Wales up to 2001.截至2001年英格兰和威尔士胃癌患者的生存率。
Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S16-8. doi: 10.1038/sj.bjc.6604574.
8
Survival from cancer of the oesophagus in England and Wales up to 2001.截至2001年英格兰和威尔士食管癌患者的生存率。
Br J Cancer. 2008 Sep 23;99 Suppl 1(Suppl 1):S11-3. doi: 10.1038/sj.bjc.6604572.
9
Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.12种癌症确诊时保险状况及种族与癌症分期的关联:一项回顾性分析
Lancet Oncol. 2008 Mar;9(3):222-31. doi: 10.1016/S1470-2045(08)70032-9. Epub 2008 Feb 20.
10
Risk factor measurement quality in primary care routine data was variable but nondifferential between individuals.基层医疗常规数据中风险因素的测量质量存在差异,但个体之间无差异。
J Clin Epidemiol. 2008 Mar;61(3):261-267. doi: 10.1016/j.jclinepi.2007.05.020. Epub 2007 Nov 26.